---
document_datetime: 2023-09-21 20:01:21
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/steps-after-cutoff/helixate-nexgen-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
document_name: helixate-nexgen-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
version: success
processing_time: 1.1731597
conversion_datetime: 2025-12-26 18:57:00.08441
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## STEPS TAKEN AFTER GRANTING THE MARKETING AUTHORISATION

For procedures finalised after 1 January 2003 please refer to module 8B.

- The MAH in accordance with Commission Regulation (EC) No. 542/95, as amended, submitted an application for a Type I variation that referred to the addition of an alternative packaging site. A notification was issued on 12 October 2000.
- The Manufacturing Authorisation Holder (MAH), in accordance with Commission Regulation (EC)  No.  542/95,  as  amended,  submitted  an  application  for  a  Type  II  variation  procedure regarding the update of the Plasma Master File. A positive opinion was adopted by the CPMP on 19 October 2000.

| Scope                                                                                                  | Application number   | Type of modification 1   | Notification/ Opinion issued on 2   | Commission Decision Issued/amen ded on   |
|--------------------------------------------------------------------------------------------------------|----------------------|--------------------------|-------------------------------------|------------------------------------------|
| Quality changes Alternative fermenter size                                                             | II/01                | II                       | 16.11.00                            | 23.11.00                                 |
| Update of or change(s) to the pharmaceutical documentation                                             | II/04                | II                       | 30.05.02                            | 05.06.02                                 |
| Change in storage conditions                                                                           | I/06                 | I                        | 13.08.01                            | 24.10.01                                 |
| Quality changes                                                                                        | II/07                | II                       | 13.12.01                            | 17.12.01                                 |
| Minor changes in manufacture of the medicinal product and Change in the batch size of finished product | I/08                 | I                        | 25.04.02                            | 30.04.02                                 |
| Update of Summary of Product Characteristics and Package Leaflet                                       | II/09                | II                       | 19.09.02                            | 05.12.02                                 |
| Change(s) to the test method(s) and/or specifications for the active substance                         | II/10 no longer      | II                       | 19.09.02                            | 25.09.02                                 |
| Quality changes                                                                                        | II/11                | II                       | 17.10.02                            | 23.10.02                                 |
| Change in or addition of manufacturing site(s) for part or all of the manufacturing process            | I/12                 | I                        | 13.12.02                            | 31.01.03                                 |

<!-- image -->